psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2725 |
4. Check minimum number of eventsNone |
2725 |
5. Include endpointsNone |
2725 |
6. Filter based on genotype QC (FinnGen only) |
2634 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified psoriasis
based on the number of shared cases.
Similar with more cases:
- Psoriasis
- Papulosquamous disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17507 | 7898 | 9423 |
| Only index persons | 14685 | 6954 | 7731 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.23 | 0.26 |
| Only index persons | 0.28 | 0.26 | 0.30 |
| Median age at first event (years) | |||
| Whole population | 50.61 | 51.59 | 49.78 |
| Only index persons | 49.46 | 50.13 | 48.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2634 | 1299 | 1335 |
| Unadjusted period prevalence (%) | 0.54 | 0.46 | 0.61 |
| Median age at first event (years) | 53.01 | 51.49 | 54.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2725
- Matched controls
- 27250
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07AB02
ATC
hydrocortisone butyrate; topical
4.4
313.0
1356
5054
L40
ICD-10 Finland
Psoriasis
69.5
307.7
501
88
E000001, ,
ATC
7.0
307.7
1267
3013
D05AX03
ATC
calcitriol; topical
165.8
307.7
456
33
L40.9
ICD-10 Finland
Psoriasis, unspecified
1101.1
307.7
1558
33
D07XC01
ATC
betamethasone; topical
22.6
307.7
1591
1590
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.3
307.7
713
1446
L01BA01
ATC
methotrexate; systemic
11.9
307.7
362
345
S91
ICPC
Psoriasis
128.4
307.7
277
24
D05AX52
ATC
calcipotriol, combinations; topical
96.9
307.7
1502
341
D07AC01
ATC
betamethasone; topical
9.2
307.7
2016
6419
E000003, ,
ATC
10.6
307.7
399
433
D05BB02
ATC
acitretin; oral
126.9
307.7
700
74
L40.8
ICD-10 Finland
Other psoriasis
1055.7
307.7
913
13
L40.5
ICD-10 Finland
Arthropathic psoriasis
756.0
307.7
547
9
D05AX02
ATC
calcipotriol; topical
109.9
307.7
1232
203
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
743.1
307.7
629
11
L40.0
ICD-10 Finland
Psoriasis vulgaris
416.2
307.7
1509
81
D07AD01
ATC
clobetasol; topical
10.4
307.7
1349
2344
L04AX03
ATC
methotrexate; systemic
13.0
307.7
1006
1170
E0000UV, ,
ATC
7.5
307.7
2012
7486
D07AC13
ATC
mometasone; topical
4.9
307.7
1433
5021
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
307.7
560
*
E000002, ,
ATC
5.8
303.7
665
1434
D05AA
ATC
Tars
63.5
301.9
167
28
L04AB04
ATC
adalimumab; parenteral
15.6
298.0
267
189
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
293.1
276
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
28.0
282.7
193
74
D07AB08
ATC
desonide; topical
5.3
264.4
629
1448
M07.3
ICD-10 Finland
Other psoriatic arthropathies
310.9
252.4
253
9
L04AC10
ATC
secukinumab; parenteral
115.1
237.0
121
11
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
35.0
235.1
149
45
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.0
214.0
423
816
L04AC05
ATC
ustekinumab; parenteral
60.5
208.0
116
20
A07EC01
ATC
sulfasalazine; oral, rectal
5.3
204.1
463
1010
TQW80
NOMESCO Finland
Local dermatologic skincare
10.4
199.7
230
240
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
191.3
504
1243
D02AE01
ATC
carbamide; topical
5.7
187.2
385
767
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
9.6
185.6
226
254
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.3
181.9
970
3883
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
9.1
181.0
230
273
134
Kela drug reimbursment
General erythroderma
381.9
180.8
180
5
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
168.5
160
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.0
156.3
373
842
E000006, ,
ATC
5.0
149.0
354
795
L04AB01
ATC
etanercept; parenteral
12.2
135.8
138
119
L40.4
ICD-10 Finland
Guttate psoriasis
433.8
125.9
125
*
L04AD01
ATC
ciclosporin; systemic
9.9
123.6
145
154
L04AA13
ATC
[U] leflunomide
8.3
121.7
164
208
L04AA01
ATC
[U] ciclosporin
11.6
118.3
124
112
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.8
112.8
737
3184
L04AC13
ATC
ixekizumab; parenteral
282.0
106.7
108
*
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
103.8
99
*
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
102.8
98
*
E000007, ,
ATC
4.6
98.6
252
595
D02AX
ATC
Other emollients and protectives
6.2
94.7
168
287
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
41.6
94.3
57
14
D07XB01
ATC
flumetasone; topical
14.6
94.0
85
60
L04AA32
ATC
apremilast; oral
+∞
92.2
88
*
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
84.8
81
*
D07AA02
ATC
hydrocortisone; topical
2.8
84.1
496
2002
H02AB06
ATC
prednisolone; systemic
2.2
82.5
1459
9489
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
80.8
1419
9179
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.1
78.8
362
1269
L88
ICPC
Rheumatoid/seropositive arthritis
4.8
78.2
186
413
L04AC16
ATC
guselkumab; systemic
769.5
76.7
75
*
D07BC01
ATC
betamethasone and antiseptics; topical
2.8
74.9
448
1814
L04AA11
ATC
[U] etanercept
21.6
68.4
51
24
L04AC18
ATC
risankizumab; parenteral
+∞
68.0
65
*
A46
ICD-10 Finland
Erysipelas
2.5
67.9
510
2301
69600
ICD-8 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
62.7
60
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
58.3
307
1154
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.8
57.9
315
1205
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.4
56.7
434
1962
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.8
53.4
99
176
D05AX05
ATC
tazarotene; topical
187.0
53.1
55
*
E000004, ,
ATC
5.5
52.0
102
191
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.6
51.8
99
181
D09AB01
ATC
zinc bandage without supplements; topical
5.6
50.6
97
178
D07CC01
ATC
betamethasone and antibiotics; topical
2.4
50.5
417
1944
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
496.7
49.5
49
*
L43.8
ICD-10 Finland
Other lichen planus
13.3
49.4
47
36
D05AC01
ATC
dithranol; topical
129.9
47.9
51
*
XQ848
NOMESCO Finland
Dermatological photography
4.3
46.0
120
286
N02AX02
ATC
tramadol; systemic, rectal
1.8
45.1
1226
8602
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.9
44.6
99
207
M13.9
ICD-10 Finland
Arthritis, unspecified
2.7
44.1
258
1020
J01FF01
ATC
clindamycin; systemic
1.9
43.2
793
4933
J01DB01
ATC
cefalexin; oral
2.0
41.1
2246
19096
L40.1
ICD-10 Finland
Generalized pustular psoriasis
403.4
40.2
40
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
40.0
895
5884
L30.3
ICD-10 Finland
Infective dermatitis
3.5
38.5
134
392
XQ802
NOMESCO Finland
Epicutan test
3.4
38.3
141
428
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
37.5
299
1364
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
6.0
37.3
66
112
M25.5
ICD-10 Finland
Pain in joint
1.7
37.2
885
5894
C03CA01
ATC
furosemide; systemic
1.8
36.3
787
5098
H02AB07
ATC
prednisone; oral
2.1
36.1
407
2133
TNG10
NOMESCO Finland
Puncture of knee
6.3
35.2
59
95
S29
ICPC
Skin symptom/complaint other
1.9
34.4
534
3120
A02BC02
ATC
pantoprazole; systemic
1.7
34.2
1832
14965
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
33.9
802
5309
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
33.4
32
*
L04AB06
ATC
golimumab; parenteral
7.8
33.2
46
60
Z3231
NOMESCO Finland
Registered nurse
1.7
32.8
746
4875
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
32.1
130
419
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
31.7
281
1338
D07AC14
ATC
methylprednisolone aceponate; topical
2.9
31.5
156
564
RJ411, ,
NOMESCO Finland
8.3
31.3
41
50
D05AX
ATC
Other antipsoriatics for topical use
111.3
30.7
33
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.1
30.6
84
208
E66.8
ICD-10 Finland
Other obesity
2.7
30.5
174
677
N05BB01
ATC
hydroxyzine; systemic
2.6
30.5
188
761
L28
ICPC
Limited function/disability (L)
1.9
30.3
473
2758
S97
ICPC
Chronic ulcer skin
2.5
29.2
190
789
WZA10
NOMESCO Finland
Extensive medical or dental certificate
4.9
28.8
63
130
R60.0
ICD-10 Finland
Localized oedema
2.0
28.8
336
1775
L04AB05
ATC
certolizumab pegol; parenteral
10.8
28.7
31
29
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
28.4
294
1485
299, ,
Kela drug reimbursment
+∞
28.2
27
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
27.8
757
5150
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
27.8
1080
8007
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
27.4
650
4267
L26
ICD-10 Finland
Exfoliative dermatitis
30.4
27.2
36
12
S76
ICPC
Skin infection other
2.6
27.2
166
668
J01DA01
ATC
[U] cefalexin
1.6
27.2
1621
13208
D07XB02
ATC
triamcinolone; topical
4.8
27.1
61
129
ZY010
NOMESCO Finland
Hospital outpatient
2.7
27.0
150
576
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
27.0
726
4919
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
26.9
366
2036
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
26.8
365
2030
RJ421, ,
NOMESCO Finland
9.8
26.8
31
32
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
26.6
210
951
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
26.4
658
4367
L04AX01
ATC
azathioprine; systemic
2.8
26.0
135
500
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
25.9
270
1366
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
25.6
316
1699
L43.9
ICD-10 Finland
Lichen planus, unspecified
7.3
25.4
37
51
Z2446
NOMESCO Finland
Social worker
2.3
25.3
193
861
R06AE07
ATC
cetirizine; oral
1.5
25.0
1101
8336
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
25.0
1569
12819
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
24.7
192
863
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.1
24.6
251
1260
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
5.0
24.4
52
105
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
24.3
155
637
D07AB01
ATC
clobetasone; topical
3.1
24.2
101
331
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
24.2
455
2791
K50.1
ICD-10 Finland
Crohn disease of large intestine
5.1
24.0
50
99
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
23.8
658
4466
D01AC02
ATC
miconazole; topical
2.1
23.8
226
1103
A10BA02
ATC
metformin; oral
1.6
23.8
749
5248
L17
ICPC
Foot/toe symptom/complaint
1.6
23.4
733
5125
UJF32
NOMESCO Finland
Coloscopy
1.6
23.1
683
4708
R4110
NOMESCO Finland
Physiotherapy
1.6
23.0
723
5055
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.9
22.9
340
1940
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
22.4
295
1618
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
22.4
347
2006
NG1DA
NOMESCO Finland
X-ray of knees
3.8
22.1
67
179
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
21.6
570
3814
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
21.5
191
908
RJ420, ,
NOMESCO Finland
7.9
21.3
29
37
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
21.2
132
536
L04AK01
ATC
leflunomide; oral
7.0
21.2
32
46
E66.00
ICD-10 Finland
Metabolic syndrome
2.3
21.1
169
769
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
4.5
20.8
50
112
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.3
20.5
53
126
M04AA01
ATC
allopurinol; systemic
1.8
20.3
347
2063
K50.8
ICD-10 Finland
Other Crohn disease
4.0
20.3
57
144
H02AB04
ATC
methylprednisolone; systemic
1.7
20.3
373
2265
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.1
20.2
42
83
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
20.2
767
5569
ZXE00
NOMESCO Finland
One hour or less
1.5
20.1
976
7453
G47.3
ICD-10 Finland
Sleep apnoea
1.6
20.0
610
4214
J02AC01
ATC
fluconazole; systemic
1.5
19.9
927
7014
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
19.9
289
1636
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
19.8
433
2755
M45
ICD-10 Finland
Ankylosing spondylitis
3.4
19.8
73
222
L04AC21
ATC
bimekizumab; systemic
+∞
19.8
19
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
19.8
302
1735
Z2221
NOMESCO Finland
Medical doctor
1.5
19.7
685
4874
N06AX11
ATC
mirtazapine; oral
1.5
19.7
839
6233
M01CB01
ATC
sodium aurothiomalate; parenteral
4.6
19.6
46
101
WQ031, ,
NOMESCO Finland
201.4
19.6
20
*
S18
ICPC
Laceration/cut
1.5
19.5
1149
9090
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.4
19.4
132
559
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
19.4
228
1203
Z3226
NOMESCO Finland
Physiotherapist
1.6
19.2
466
3047
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
19.1
313
1836
S21
ICPC
Skin texture symptom/complaint
1.7
19.1
357
2176
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.6
19.0
63
179
AA1AD
NOMESCO Finland
CT of head and brain
1.5
19.0
677
4838
L30.4
ICD-10 Finland
Erythema intertrigo
4.1
18.9
51
125
N05CF01
ATC
zopiclone; oral
1.5
18.9
803
5953
M07.1*L40.5
ICD-10 Finland
Arthritis mutilans
+∞
18.8
18
*
L40.2
ICD-10 Finland
Acrodermatitis continua
+∞
18.8
18
*
D07AC03
ATC
desoximetasone; topical
3.7
18.6
59
163
M54.5
ICD-10 Finland
Low back pain
1.5
18.5
881
6675
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.3
18.5
69
212
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
18.4
270
1532
S02CA02
ATC
flumetasone and antiinfectives; otic
2.2
18.3
156
729
R03AC02
ATC
salbutamol; inhalant
1.4
18.3
1363
11219
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
18.2
867
6562
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.3
18.1
143
648
T82
ICPC
Obesity
2.5
18.0
110
443
R4180
NOMESCO Finland
Podiatric therapy
4.2
18.0
48
117
SPAT1262
SPAT
Handing over of treatment supplies
1.6
17.9
447
2937
SPAT1263
SPAT
Sampling
1.4
17.8
1005
7851
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
17.5
190
973
WX110, ,
SPAT
2.1
17.5
164
795
N02BE01
ATC
paracetamol; systemic, rectal
1.6
17.5
2322
21262
R50.9
ICD-10 Finland
Fever, unspecified
1.7
17.5
379
2402
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.6
17.4
100
391
L08.0
ICD-10 Finland
Pyoderma
5.1
17.4
36
71
D07XB05
ATC
dexamethasone; topical
3.0
17.4
76
257
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
17.3
170
840
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
17.2
104
417
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
17.1
315
1909
M01AH01
ATC
celecoxib; oral
1.6
17.1
446
2959
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
17.1
251
1423
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
17.1
217
1175
T90
ICPC
Diabetes non-insulin dependent
1.5
16.9
601
4278
A07EC02
ATC
mesalazine; oral, rectal
2.2
16.8
146
687
N05CD07
ATC
temazepam; oral
1.8
16.8
292
1742
EBA00
NOMESCO Finland
Extraction of tooth
1.4
16.7
873
6701
N06AB04
ATC
citalopram; systemic
1.6
16.7
511
3519
R06.0
ICD-10 Finland
Dyspnoea
1.5
16.6
656
4770
J01MA02
ATC
ciprofloxacin; systemic
1.4
16.6
972
7620
SPAT1254
SPAT
Administration of medicine
1.7
16.5
348
2188
XQ800
NOMESCO Finland
Prick test
2.0
16.5
182
938
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
5.1
16.5
34
67
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.1
16.4
70
233
A10BJ02
ATC
liraglutide; parenteral
2.7
16.2
88
335
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.0
16.2
189
994
ZXD05
NOMESCO Finland
Urgent procedure
1.5
16.1
738
5522
D01AE15
ATC
terbinafine; topical
2.0
16.0
188
990
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
16.0
165
830
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
16.0
1790
15653
WQ021, ,
NOMESCO Finland
21.1
16.0
23
11
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.9
15.9
195
1042
R03BB04
ATC
tiotropium bromide; inhalant
1.8
15.8
265
1564
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.2
15.8
63
202
SFA30
NOMESCO Finland
Three-surface restoration
1.4
15.6
1057
8477
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
15.5
110
475
Z71.8
ICD-10 Finland
Other specified counselling
1.5
15.4
729
5478
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
15.4
290
1769
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.2
15.3
40
96
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
15.2
135
641
M79.6
ICD-10 Finland
Pain in limb
1.4
15.2
1008
8042
C03DA01
ATC
spironolactone; oral
1.7
15.2
294
1805
A03
ICPC
Fever
1.6
15.2
380
2492
L60.0
ICD-10 Finland
Ingrowing nail
2.2
15.2
125
576
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
15.0
389
2572
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.3
15.0
38
89
A02BC01
ATC
omeprazole; systemic
1.5
15.0
655
4845
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.6
14.9
48
134
J01MA12
ATC
levofloxacin; systemic
1.5
14.8
462
3186
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
14.8
153
770
A28
ICPC
Limited function/disability NOS
1.6
14.8
393
2613
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
3.7
14.7
46
126
N05BA04
ATC
oxazepam; oral
1.5
14.7
611
4473
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
14.7
627
4615
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
14.7
415
2801
A10BJ06
ATC
semaglutide; parenteral
2.1
14.6
139
679
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
14.6
870
6806
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
14.5
177
945
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
14.5
256
1532
R4120
NOMESCO Finland
Occupational therapy
1.9
14.5
174
924
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.6
14.4
392
2620
C07AB07
ATC
bisoprolol; oral
1.4
14.4
1192
9840
C09AA02
ATC
enalapril; systemic
1.5
14.3
465
3234
A06AD11
ATC
lactulose; oral
1.6
14.2
344
2238
D01AC03
ATC
econazole; topical
2.0
14.1
166
875
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
14.1
447
3092
L20
ICPC
Joint symptom/complaint NOS
2.4
14.0
92
384
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
14.0
880
6936
L21.0
ICD-10 Finland
Seborrhoea capitis
3.9
14.0
40
103
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.0
13.9
156
809
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.9
13.9
63
218
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
13.8
309
1969
A10BB12
ATC
glimepiride; oral
1.9
13.8
169
904
M10.9
ICD-10 Finland
Gout, unspecified
1.9
13.7
180
984
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.6
13.7
76
293
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
13.7
457
3196
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
13.6
1345
11382
WQ032, ,
NOMESCO Finland
+∞
13.5
13
*
L04AA21
ATC
[U] efalizumab
+∞
13.5
13
*
M09.0*L40.5
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
13.5
13
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.8
13.5
30
63
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
13.5
127
617
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
13.5
384
2591
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
13.5
171
925
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
13.4
284
1784
D06AX01
ATC
fusidic acid; topical
1.8
13.4
228
1351
A10BH01
ATC
sitagliptin; oral
1.7
13.4
243
1466
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
13.4
389
2639
L43.0
ICD-10 Finland
Hypertrophic lichen planus
25.9
13.4
18
7
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
4.6
13.3
31
68
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
13.3
999
8092
A10AE04
ATC
insulin glargine; parenteral
1.7
13.2
245
1487
J01CF05
ATC
flucloxacillin; systemic
1.9
13.2
160
853
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
13.2
244
1480
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
13.0
109
507
EB1AA, ,
SPAT
1.9
13.0
171
937
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
12.9
446
3140
N06AB10
ATC
escitalopram; oral
1.5
12.9
455
3217
L30.0
ICD-10 Finland
Nummular dermatitis
2.3
12.7
99
447
K02.1
ICD-10 Finland
Caries of dentine
1.3
12.7
1423
12223
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
4.4
12.6
31
71
E66.9
ICD-10 Finland
Obesity, unspecified
2.3
12.6
95
423
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
12.5
1092
9025
C08CA01
ATC
amlodipine; oral
1.4
12.5
914
7350
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
12.5
250
1547
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
12.5
111
528
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
12.5
95
424
J01DA09
ATC
[U] cefadroxil
1.4
12.5
630
4764
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.1
12.4
117
570
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.7
12.4
38
103
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.8
12.4
62
227
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.4
12.3
80
333
M05BA04
ATC
alendronic acid; oral
1.8
12.3
185
1057
N07BB01
ATC
disulfiram; oral
2.1
12.3
115
559
J01AA02
ATC
doxycycline; systemic
1.4
12.2
1967
17795
N05BA01
ATC
diazepam; systemic, rectal
1.6
12.2
311
2044
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
12.2
209
1240
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
12.1
125
630
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
12.1
140
735
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.2
12.0
46
144
N03AX16
ATC
[U] pregabalin
1.4
12.0
554
4117
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.8
12.0
58
208
N03AX12
ATC
[U] gabapentin; oral
1.5
12.0
393
2732
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.5
11.9
72
290
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.9
11.9
26
54
EB1SA, ,
SPAT
2.0
11.9
131
676
K08.3
ICD-10 Finland
Retained dental root
1.8
11.9
183
1053
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
11.8
438
3121
M01AH02
ATC
rofecoxib; oral
1.6
11.8
297
1946
ZX120
NOMESCO Finland
Intravenous
1.7
11.8
228
1398
N06AX21
ATC
duloxetine; oral
1.6
11.8
273
1754
M01AE02
ATC
naproxen; oral, rectal
1.3
11.8
1370
11777
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
11.8
122
616
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.0
11.8
124
630
L30.8
ICD-10 Finland
Other specified dermatitis
2.5
11.7
70
280
160
Kela drug reimbursment
exenatide
2.7
11.7
61
228
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
11.7
1668
14759
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
11.7
274
1766
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.5
11.7
71
287
L20.0
ICD-10 Finland
Besnier prurigo
1.9
11.6
154
845
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
11.6
289
1888
D05AD01
ATC
trioxysalen; topical
65.2
11.6
13
*
D11AH04
ATC
alitretinoin; oral
19.0
11.6
17
9
P01AB01
ATC
metronidazole; oral, rectal
1.3
11.6
931
7578
B01AB05
ATC
enoxaparin; parenteral
1.4
11.6
740
5812
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
11.5
107
518
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.4
11.5
78
331
WQ054, ,
NOMESCO Finland
+∞
11.5
11
*
RS221, ,
NOMESCO Finland
3.2
11.4
43
134
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
11.4
114
569
D07AC09
ATC
budesonide; topical
11.8
11.3
20
17
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
11.3
150
825
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
11.2
304
2026
D07CB01
ATC
triamcinolone and antibiotics; topical
2.8
11.2
56
205
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
11.2
65
257
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
11.2
84
374
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
11.1
268
1737
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
3.7
11.1
34
92
J01FA06
ATC
roxithromycin; oral
1.3
11.1
950
7792
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.3
11.1
81
356
SPAT1229
SPAT
Assessment of need for aid
1.8
11.1
176
1022
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.3
11.1
80
350
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
5.3
11.1
22
42
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
11.1
164
933
L04AA17
ATC
[U] adalimumab
8.6
11.0
23
27
D11
ICPC
Diarrhoea
1.6
11.0
256
1647
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.6
11.0
62
242
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
10.9
256
1648
WQ066, ,
NOMESCO Finland
43.5
10.9
13
*
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.7
10.9
59
225
WX290
NOMESCO Finland
Other blockage of nerve
1.3
10.9
1085
9090
M01AH05
ATC
etoricoxib; oral
1.3
10.8
1515
13299
P01BA02
ATC
hydroxychloroquine; oral
1.7
10.7
183
1084
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
10.7
534
4018
N06AX16
ATC
venlafaxine; oral
1.5
10.6
321
2190
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
10.6
233
1476
WX402
NOMESCO Finland
General anaesthesia
1.4
10.6
500
3722
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
10.6
129
689
A10AB05
ATC
insulin aspart; parenteral
1.7
10.6
183
1088
SPAT1255
SPAT
Intravenous administration of medicine
1.8
10.6
168
975
R02
ICPC
Shortness of breath/dyspnoea
1.5
10.6
296
1987
N05AH04
ATC
quetiapine; oral
1.5
10.6
394
2808
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
10.5
587
4497
Z02.7
ICD-10 Finland
Issue of medical certificate
1.8
10.5
165
955
WX290, ,
SPAT
2.2
10.5
86
397
J01DA06
ATC
[U] cefuroxime
1.5
10.5
334
2305
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.8
10.5
52
190
M073, L409,
ICD-10 Finland
+∞
10.4
10
*
WQ053, ,
NOMESCO Finland
+∞
10.4
10
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
10.3
1075
9041
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.0
10.2
106
536
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
10.2
124
663
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.7
10.1
52
194
A10AE05
ATC
insulin detemir; parenteral
1.9
10.1
131
716
SFA10
NOMESCO Finland
One-surface restoration
1.3
10.0
1298
11228
A07EA06
ATC
budesonide; oral, local oral
2.2
10.0
85
399
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.0
10.0
42
140
QXA70
NOMESCO Finland
Guidance related to rash and skin care
40.2
10.0
12
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
10.0
109
562
ZX112
NOMESCO Finland
Subcutaneous
2.5
9.9
59
236
SPAT1211
SPAT
Application of soft bandage
1.7
9.9
197
1217
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
9.9
191
1171
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
3.2
9.9
38
120
N02BF02
ATC
pregabalin; oral
1.8
9.8
138
772
R53
ICD-10 Finland
Malaise and fatigue
1.4
9.8
527
4007
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
9.8
527
4010
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
9.8
292
1987
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
9.8
1736
15630
S94
ICPC
Ingrowing nail
2.9
9.6
45
159
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.1
9.6
87
418
205
Kela drug reimbursment
Chronic hypertension
1.4
9.6
616
4819
M01AC06
ATC
meloxicam; systemic, rectal
1.3
9.6
846
6936
G72.8
ICD-10 Finland
Other specified myopathies
2.9
9.6
44
154
4AA12, ,
NOMESCO Finland
9.1
9.5
19
21
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
9.5
518
3948
L84
ICD-10 Finland
Corns and callosities
2.1
9.5
85
407
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.3
9.4
35
108
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.9
9.4
42
145
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
9.4
652
5164
256, ,
Kela drug reimbursment
12.4
9.3
16
13
RS340, ,
NOMESCO Finland
12.4
9.3
16
13
A10AC01
ATC
insulin (human); parenteral
1.7
9.3
175
1065
J01FA10
ATC
azithromycin; systemic
1.3
9.3
1347
11772
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
9.2
81
385
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
9.2
146
848
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.5
9.2
56
227
B37.2
ICD-10 Finland
Candidiasis of skin and nail
3.9
9.1
26
67
Z72.1
ICD-10 Finland
Alcohol use
3.0
9.1
38
126
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.4
9.1
520
3991
R05
ICPC
Cough
1.4
9.1
526
4047
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.1
9.0
83
402
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.9
9.0
103
540
Z01.2
ICD-10 Finland
Dental examination
1.3
9.0
1033
8758
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.5
9.0
54
218
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.2
8.9
73
338
S01BA01
ATC
dexamethasone; ophthalmic
2.1
8.9
83
405
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
8.8
398
2933
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.1
8.8
80
385
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
8.8
511
3930
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
8.8
102
537
R06AX27
ATC
desloratadine; oral
1.3
8.8
612
4842
J01FA01
ATC
erythromycin; systemic
1.5
8.8
288
1999
RS222, ,
NOMESCO Finland
3.3
8.8
32
98
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
8.7
79
380
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
8.7
499
3827
L99
ICPC
Musculoskeletal disease other
2.6
8.7
49
191
L16
ICPC
Ankle symptom/complaint
1.5
8.7
252
1702
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
3.0
8.7
37
124
R03AK03
ATC
[U] fenoterol and ipratropium bromide
1.8
8.7
118
654
L71.8
ICD-10 Finland
Other rosacea
2.8
8.7
43
157
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
8.7
409
3038
L03
ICD-10 Finland
Cellulitis
3.6
8.7
28
79
P15
ICPC
Chronic alcohol abuse
2.1
8.6
76
362
D06BB04
ATC
podophyllotoxin; topical
1.9
8.6
105
563
R11
ICD-10 Finland
Nausea and vomiting
1.6
8.6
183
1153
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.4
8.5
59
254
291
Kela drug reimbursment
Tofacitinib
9.0
8.5
17
19
N05AA02
ATC
levomepromazine; systemic
1.9
8.5
97
508
WYA30, ,
SPAT
3.8
8.5
25
66
M01AX01
ATC
nabumetone; oral
1.9
8.5
97
509
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.1
8.4
34
111
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
8.4
119
670
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.3
612
4873
WX780
NOMESCO Finland
Remote monitoring CPAP
1.9
8.3
107
583
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.3
8.3
31
96
SPAT1312
SPAT
General health counselling
1.3
8.3
687
5561
H01
ICPC
Ear pain/earache
1.5
8.3
233
1563
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
8.3
591
4683
A02BC05
ATC
esomeprazole; systemic
1.3
8.3
945
7978
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
4.0
8.3
23
58
212
Kela drug reimbursment
Gout
2.6
8.3
48
190
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
8.3
490
3775
N07BA03
ATC
varenicline; oral
1.9
8.3
108
591
E66
ICD-10 Finland
Obesity
1.8
8.3
115
642
M10.0
ICD-10 Finland
Idiopathic gout
2.0
8.3
84
422
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
8.3
622
4968
A08
ICPC
Swelling
1.8
8.3
116
650
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
9.5
8.3
16
17
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic
2.2
8.3
67
309
M01AB05
ATC
diclofenac; systemic, rectal
1.3
8.3
1619
14594
M01CB03
ATC
auranofin; oral
4.1
8.3
22
54
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
8.3
117
658
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
8.3
646
5191
WX320
NOMESCO Finland
Spinalanesthesy
1.3
8.2
552
4337
S22.3
ICD-10 Finland
Fracture of rib
1.6
8.2
172
1078
Z01.7
ICD-10 Finland
Laboratory examination
1.4
8.2
324
2333
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
7.5
8.1
18
24
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
8.1
174
1097
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
4.8
8.1
18
38
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.6
8.1
45
175
K07
ICPC
Swollen ankles/oedema
1.9
8.1
100
539
SPAT1301
SPAT
No procedures
1.3
8.1
686
5573
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.5
8.1
49
199
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.5
8.1
285
2007
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
3.3
8.1
29
88
J01AA07
ATC
tetracycline; systemic
1.4
8.0
315
2262
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
8.0
273
1907
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
8.0
133
783
B35.3
ICD-10 Finland
Tinea pedis
1.9
8.0
98
526
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.4
8.0
51
212
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.3
8.0
56
243
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
8.0
170
1071
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
7.9
122
704
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.9
654
5291
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.5
7.9
47
189
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
4.0
7.9
22
56
162
Kela drug reimbursment
liraglutide
2.9
7.9
35
121
XX9XE
NOMESCO Finland
Other ultrasound examination
3.6
7.8
25
70
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.5
7.8
48
196
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.1
7.8
71
343
WZC30
NOMESCO Finland
Teaching
1.4
7.8
366
2714
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
7.8
1086
9379
3029
Kela drug reimbursment
Upadacitinib
8.5
7.8
16
19
298, ,
Kela drug reimbursment
8.5
7.8
16
19
K70.1
ICD-10 Finland
Alcoholic hepatitis
4.1
7.8
21
52
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
3.2
7.8
29
90
EBA30
NOMESCO Finland
Extraction of root of tooth
1.7
7.8
134
798
L12
ICPC
Hand/finger symptom/complaint
1.4
7.8
347
2552
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
7.0
7.8
18
26
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.1
7.8
68
324
P06
ICPC
Sleep disturbance
1.5
7.8
254
1762
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.5
7.7
274
1930
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.7
983
8398
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.7
848
7116
M40.5
ICD-10 Finland
Lordosis, unspecified
45.1
7.7
9
*
XX9XT
NOMESCO Finland
Other radiological intervention
45.1
7.7
9
*
EBA10
NOMESCO Finland
Operative extraction of tooth
1.5
7.7
251
1739
H60.1
ICD-10 Finland
Cellulitis of external ear
3.1
7.7
31
101
F10.24
ICD-10 Finland
Alcohol depence active use
2.6
7.7
42
162
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
4.3
7.7
19
44
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
7.6
1556
14027
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.3
7.6
53
230
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
7.6
119
691
N06AB03
ATC
fluoxetine; oral
1.5
7.5
272
1925
WX002
NOMESCO Finland
Sedation and analgesia
1.4
7.5
434
3331
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
7.5
52
225
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
7.5
604
4867
B07.9
ICD-10 Finland
Verruca simplex
2.0
7.5
79
404
R52.9
ICD-10 Finland
Pain, unspecified
1.5
7.5
208
1395
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
2.6
7.5
40
153
R21
ICPC
Throat symptom/complaint
1.4
7.4
409
3113
W19
ICD-10 Finland
Unspecified fall
1.5
7.4
204
1364
WQ022, ,
NOMESCO Finland
80.3
7.4
8
*
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
80.3
7.4
8
*
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.5
7.4
44
177
B01AB10
ATC
tinzaparin; parenteral
1.5
7.4
225
1537
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
3.1
7.4
29
93
XG466
NOMESCO Finland
Sleep oxymetry
2.0
7.4
75
378
R5110, ,
SPAT
1.7
7.4
141
864
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
7.4
999
8586
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.3
255
1790
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.3
872
7378
A10BB01
ATC
glibenclamide; oral
1.9
7.3
83
435
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
3.6
7.3
23
64
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.2
7.3
58
266
N06AA09
ATC
amitriptyline; systemic
1.5
7.3
208
1402
M09.0
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
7.3
7
*
M07
ICD-10 Finland
Psoriatic and enteropathic arthropathies
+∞
7.3
7
*
R48
ICPC
Respiratory, Clarification/discussion RFE/demand
4.2
7.3
19
46
J20
ICD-10 Finland
Acute bronchitis
1.5
7.3
215
1461
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
7.2
109
625
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
3.8
7.2
21
55
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
7.2
185
1217
R4190
NOMESCO Finland
Nutritional therapy
1.9
7.2
81
423
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.2
867
7343
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
7.2
153
964
L04AB02
ATC
infliximab; parenteral
4.5
7.2
17
38
M79.7
ICD-10 Finland
Fibromyalgia
2.0
7.2
71
355
SPAT1104
SPAT
Monitoring of emergency patient
1.6
7.2
142
879
OAB50, ,
SPAT
1.7
7.1
126
756
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.6
7.1
23
65
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.5
7.1
208
1409
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
7.1
247
1733
SGA01
NOMESCO Finland
Emergency treatment
1.4
7.1
351
2624
J02AC02
ATC
itraconazole; systemic
1.4
7.1
385
2922
M01AB01
ATC
indometacin; systemic, rectal
1.6
7.1
176
1150
L60.9
ICD-10 Finland
Nail disorder, unspecified
2.5
7.1
41
163
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
8.8
7.0
14
16
JN4AD
NOMESCO Finland
Body CT examination
1.5
7.0
226
1562
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
3.6
7.0
22
61
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
3.6
7.0
22
61
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.5
7.0
41
164
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.9
7.0
82
435
B01AC04
ATC
clopidogrel; oral
1.4
7.0
363
2737
4AB02, ,
NOMESCO Finland
7.0
7.0
16
23
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
3.5
7.0
23
66
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.1
7.0
61
291
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.2
7.0
55
252
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.8
6.9
92
508
L20.8
ICD-10 Finland
Other atopic dermatitis
3.0
6.9
29
97
ZXA10
NOMESCO Finland
Bilateral
1.4
6.9
387
2954
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.9
606
4933
M10
ICD-10 Finland
Gout
1.8
6.9
100
568
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
6.9
110
643
A01AB09
ATC
miconazole; local oral
1.6
6.8
177
1168
N05CF02
ATC
zolpidem; oral
1.4
6.8
379
2887
R42
ICD-10 Finland
Dizziness and giddiness
1.3
6.8
477
3761
C09CA01
ATC
losartan; oral
1.3
6.8
574
4643
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
6.8
161
1040
R74
ICPC
Upper respiratory infection acute
1.3
6.8
646
5307
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
6.8
98
555
H60.8
ICD-10 Finland
Other otitis externa
2.0
6.8
69
348
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
4.1
6.8
18
44
SPE90
NOMESCO Finland
Other partial denture
2.2
6.8
52
235
N02AA05
ATC
oxycodone; systemic
1.4
6.8
381
2909
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
6.8
863
7348
SPAT1281
SPAT
Other administrative function
1.6
6.8
168
1099
A10BK01
ATC
dapagliflozin; oral
1.6
6.8
158
1019
ZXA00
NOMESCO Finland
Right side
1.3
6.7
590
4797
SPAT1283
SPAT
Restricted health certificate
1.4
6.7
315
2334
NH1AD
NOMESCO Finland
Ankle and foot CT
2.2
6.7
52
236
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.7
275
1990
L03
ICPC
Low back symptom/complaint
1.3
6.7
598
4872
K92.0
ICD-10 Finland
Haematemesis
2.2
6.7
54
249
R51.80
ICD-10 Finland
Headache
1.4
6.7
320
2378
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
3.9
6.7
19
49
C07AG02
ATC
carvedilol; oral
1.7
6.7
125
762
A02BA02
ATC
ranitidine; systemic
1.3
6.7
422
3279
E0001A1, ,
ATC
2.4
6.7
42
174
PD5YT
NOMESCO Finland
Implantation of aorttaprothesis for aortta aneurysm
22.6
6.7
9
*
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.9
6.7
85
464
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.3
6.7
49
218
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
6.6
234
1647
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
6.6
132
818
N03AE01
ATC
clonazepam; systemic
1.7
6.6
121
733
P19
ICPC
Drug abuse
3.7
6.6
20
54
I50
ICD-10 Finland
Heart failure
2.1
6.6
59
284
L04AA44
ATC
[U] upadacitinib
7.8
6.6
14
18
H60
ICD-10 Finland
Otitis externa
1.7
6.6
107
628
K04.08
ICD-10 Finland
Other specified pulpit
1.6
6.6
158
1025
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
6.6
174
1155
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
6.6
923
7941
EBA00, ,
SPAT
2.0
6.6
63
312
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
6.5
428
3343
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.6
6.5
37
146
RS121, ,
NOMESCO Finland
3.7
6.5
20
55
S22
ICPC
Nail symptom/complaint
1.6
6.5
138
871
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.9
6.5
74
390
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
6.2
6.5
16
26
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.0
6.5
62
307
I50.0
ICD-10 Finland
Congestive heart failure
1.6
6.4
145
927
L01
ICD-10 Finland
Impetigo
2.7
6.4
32
118
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
70.0
6.4
7
*
A07EA02
ATC
hydrocortisone; rectal
2.2
6.4
50
228
Z08
ICPC
Social welfare problem
2.8
6.4
31
113
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
6.4
195
1336
RS230, ,
NOMESCO Finland
4.1
6.4
17
42
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
6.3
139
883
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
2.7
6.3
32
119
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
6.6
6.3
15
23
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
6.3
43
185
KGH10
NOMESCO Finland
Operation for phimosis
2.0
6.3
61
303
SFA20
NOMESCO Finland
Two-surface restoration
1.2
6.3
1357
12195
J01FA09
ATC
clarithromycin; systemic
1.3
6.3
684
5709
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
6.3
216
1514
Z72.0
ICD-10 Finland
Tobacco use
2.1
6.3
59
290
C10AC01
ATC
colestyramine; oral
2.1
6.3
59
290
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
3.0
6.3
27
92
N07.3
ICD-10 Finland
Hereditary nephropathy, not elsewhere classified, diffuse mesangial proliferative glomerulonephritis
+∞
6.3
6
*
L405, L400,
ICD-10 Finland
+∞
6.3
6
*
M07.2
ICD-10 Finland
Psoriatic spondylitis
+∞
6.3
6
*
H10.2
ICD-10 Finland
Other acute conjunctivitis
2.7
6.2
32
120
S99
ICPC
Skin disease other
2.3
6.2
46
205
ZZH40
NOMESCO Finland
Substitute of bone
3.0
6.2
26
87
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.3
6.2
45
199
RS211, ,
NOMESCO Finland
7.0
6.2
14
20
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.2
6.2
47
212
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
6.2
79
432
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.7
6.2
117
717
78739
ICD-8 Finland
Symptoms referable to limbs and joints, Arthralgia alia sive NUD
5.0
6.2
18
36
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.6
6.2
126
787
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
6.2
307
2299
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
2.7
6.2
32
121
J01XC01
ATC
fusidic acid; systemic
2.7
6.2
32
121
NHQ40
NOMESCO Finland
Amputation of toe
2.4
6.1
38
157
N06AB06
ATC
sertraline; oral
1.4
6.1
231
1649
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
565
4622
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
6.1
85
478
RJ422, ,
NOMESCO Finland
12.5
6.1
10
8
P76
ICPC
Depressive disorder
1.6
6.1
123
767
L30
ICD-10 Finland
Other dermatitis
2.2
6.0
50
234
M66.0
ICD-10 Finland
Rupture of popliteal cyst
2.6
6.0
33
128
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
3.6
6.0
19
53
A10BX07
ATC
[U] liraglutide
2.5
6.0
35
140
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
3.2
6.0
23
73
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1799
10248
3.22
181.94
11.8
6.1
—
—
—
0
0
1852
10903
3.18
173.24
11.2
5.6
0.62
0.58
e9/l
6.17
1668
9438
1851
10927
3.16
171.62
11.3
5.6
0.05
0.04
e9/l
6.32
1669
9450
1873
11221
3.14
167.33
11.3
5.7
1.90
1.94
e9/l
0.47
1704
9942
1872
11320
3.09
162.28
11.6
5.8
0.20
0.19
e9/l
1.50
1702
9940
1702
9894
2.92
156.37
11.6
5.8
0.72
0.67
%
4.34
1654
9243
1726
10213
2.88
151.40
11.7
5.8
2.84
2.83
%
0.09
1678
9561
1731
10269
2.88
150.88
12.1
6.1
8.78
8.63
%
1.27
1684
9622
1749
10557
2.83
145.17
11.8
5.9
27.33
27.78
%
1.06
1701
9929
1729
10404
2.81
143.85
11.4
5.7
58.10
57.26
%
2.48
1681
9771
1972
12726
2.99
143.08
13.9
8.9
4.22
4.11
e9/l
1.53
1788
11110
279
612
4.96
120.02
1.6
1.6
0.73
10.40
iu/ml
0.46
42
117
87
40
22.43
118.19
1.6
1.3
9.43
8.98
ug/l
0.25
87
40
1503
9762
2.20
86.92
14.8
9.2
0.00
0.00
e9/l
0.55
1282
7985
2222
17170
2.59
82.09
11.4
7.5
80.23
78.26
u/l
1.27
2145
16218
2124
16357
2.35
74.26
6.8
3.9
14.77
11.96
mm/h
13.65
2012
15155
430
1718
2.78
73.65
5.3
4.1
0.08
0.12
%
0.69
145
556
417
1648
2.81
72.88
4.9
3.9
0.42
0.71
%
3.19
145
562
114
196
6.03
63.67
1.4
1.5
57.33
29.20
iu/ml
—
6
10
64
55
11.89
62.85
1.9
2.0
7.93
8.69
mg/l
0.37
51
46
1185
7726
1.94
60.14
4.7
3.7
85.81
102.90
e6/l
0.38
834
5513
1494
10627
1.90
57.11
6.4
4.8
0.00
0.00
estimate
0.50
353
2005
1489
10636
1.88
55.58
4.7
3.5
0.00
0.00
estimate
0.18
365
2105
1499
10749
1.88
55.08
4.8
3.5
0.00
0.00
estimate
1.08
338
1925
947
5892
1.93
53.79
2.9
2.7
1987.18
4657.47
umol/l
2.15
840
5190
643
3539
2.07
51.52
1.3
1.2
15.20
12.04
u/ml
0.40
227
1395
157
422
3.89
51.20
3.8
3.5
4.04
4.24
e9/l
0.54
157
422
665
3719
2.04
50.93
1.3
1.3
29.75
34.16
iu/ml
0.38
190
1214
158
439
3.76
49.12
3.9
3.8
55.42
58.10
%
1.99
158
439
1338
9519
1.80
47.88
5.8
5.0
34.68
35.57
g/l
6.81
1249
8906
1015
6662
1.83
47.38
4.0
3.2
46.60
90.88
e6/l
1.99
798
5142
215
769
2.95
44.42
1.2
1.2
0.31
1.07
u/ml
—
7
67
1243
8877
1.74
42.00
2.6
2.2
75.14
77.16
nmol/l
1.58
1139
7986
924
6089
1.78
41.23
3.8
3.1
0.31
0.41
e6/l
1.57
719
4650
1527
11598
1.72
40.80
7.1
6.4
11.63
11.60
umol/l
0.03
1450
11034
334
1554
2.31
40.14
1.7
1.7
—
—
—
0
0
104
254
4.22
38.62
1.7
1.6
55.30
59.92
%
0.49
65
163
51
63
8.23
38.49
3.2
3.5
7.79
8.45
mg/l
0.22
31
55
1054
7339
1.71
37.91
3.9
3.2
39.44
35.03
u/l
0.66
1000
6977
168
581
3.02
36.76
1.5
1.4
—
—
—
0
0
460
2525
1.99
35.80
3.1
2.3
144.80
136.60
ug/g
0.24
380
2017
1428
10930
1.64
34.64
8.2
7.0
1.21
1.21
mmol/l
1.70
1219
9319
536
3137
1.88
34.32
2.7
2.5
2.33
2.32
g/l
0.18
498
2922
45
55
8.30
34.25
2.8
3.1
131.16
62.77
au/ml
—
8
13
718
4617
1.75
33.57
3.1
2.6
5.42
5.45
e6/l
0.02
659
4145
398
2127
2.02
33.24
2.7
2.2
0.21
0.21
g/l
0.58
372
1989
506
2957
1.87
32.37
2.9
2.6
21.23
23.33
%
2.52
442
2540
1350
10342
1.61
31.43
16.2
15.1
1.21
1.26
inr
1.46
421
3006
559
3412
1.80
30.92
2.8
2.5
12.13
13.40
umol/l
3.49
522
3195
1306
9987
1.59
30.19
7.5
6.2
1.21
1.21
mmol/l
0.69
1230
9123
1622
13070
1.60
29.82
6.0
4.9
6.83
6.75
mmol/l
0.85
1552
12278
80
195
4.20
29.80
1.8
1.4
37.56
30.25
%
0.79
45
125
143
524
2.82
28.15
1.7
1.7
15195.94
14304.73
e6/l
0.06
102
379
559
3498
1.75
28.10
3.3
2.9
2.92
2.16
e6/l
1.03
288
1922
796
5498
1.63
27.50
2.6
2.2
3.18
2.94
mg/l
1.34
692
4680
581
3738
1.70
26.22
3.1
2.7
0.98
1.06
e6/l
0.24
313
2161
815
5720
1.61
26.11
5.5
4.0
87.32
89.87
%
2.16
796
5581
313
1667
1.99
26.08
2.4
2.7
11.02
10.51
g/l
1.18
286
1528
568
3663
1.70
25.30
3.7
3.5
0.80
0.82
mmol/l
4.37
544
3457
2445
22256
1.96
25.05
23.5
14.1
21.98
24.26
mg/l
3.21
2152
17549
621
4122
1.66
24.71
1.5
1.5
3.05
2.46
g/l
6.82
379
2560
474
2932
1.75
24.49
6.5
6.2
1.04
1.04
mmol/l
0.01
451
2732
155
636
2.52
24.39
1.8
1.6
—
—
—
0
0
414
2478
1.79
23.92
2.9
2.6
1.83
1.79
%
0.27
375
2212
1711
14323
1.52
23.64
5.5
4.3
1191.20
1628.41
e6/l
0.16
25
209
145
592
2.53
23.06
1.2
1.2
83.64
100.64
titre
0.33
11
47
47
95
5.02
22.07
1.6
1.3
6.07
4.19
%
0.28
14
21
1143
8909
1.49
21.66
2.3
2.0
93.24
94.87
pmol/l
0.62
682
4703
250
1312
2.00
21.60
1.7
1.9
1.24
1.41
g/l
0.96
235
1207
2161
19230
1.60
21.07
28.3
16.6
14.98
15.19
%
0.36
2145
18881
146
626
2.41
20.90
1.3
1.4
—
—
—
0
0
1179
9296
1.47
20.82
3.3
2.8
149.66
131.82
ug/l
1.38
1090
8604
530
3536
1.62
20.18
2.1
1.8
—
—
—
0
0
785
5733
1.52
20.05
5.5
3.9
0.00
0.00
estimate
1.08
333
1918
940
7134
1.48
19.88
3.5
3.2
7.41
7.74
mmol/l
1.41
807
6063
403
2519
1.70
19.73
3.5
2.8
9.49
8.37
umol/l
0.31
343
2216
1053
8191
1.47
19.56
5.3
3.7
—
—
—
0
0
200
1008
2.06
19.29
1.7
1.9
1.77
1.53
g/l
1.99
163
877
655
4649
1.54
18.93
1.3
1.2
2.41
1.62
u/ml
0.60
167
1256
928
7098
1.47
18.56
4.1
3.9
12.85
9.12
mg/mmol
1.18
612
4552
387
2436
1.69
18.38
1.9
1.7
—
—
—
0
0
414
2669
1.65
17.91
1.9
1.8
1.65
1.49
%
2.80
351
2354
387
2457
1.67
17.76
2.0
1.7
—
—
—
0
0
330
2027
1.71
17.10
4.4
3.9
1.92
1.99
mmol/l
0.11
284
1694
523
3609
1.56
16.94
1.6
1.5
—
—
—
0
0
392
2528
1.64
16.87
3.3
4.4
235.44
248.56
u/l
1.20
366
2406
334
2070
1.70
16.74
3.2
2.4
33.33
62.82
u/l
0.70
287
1787
900
6961
1.44
16.51
3.0
2.6
69.46
70.64
u/l
0.02
822
6447
875
6750
1.44
16.22
3.4
3.3
367.78
305.24
mg/l
0.16
594
4383
237
1347
1.83
16.01
8.8
8.0
25.02
24.92
mmol/l
0.15
237
1337
327
2039
1.69
15.99
4.4
3.9
5.82
5.86
kpa
0.29
318
1972
302
1855
1.71
15.60
2.3
2.7
68.67
70.27
e9/l
0.28
217
1415
320
2006
1.67
15.31
2.4
2.2
344.88
369.94
nmol/l
1.28
292
1847
313
1956
1.68
15.15
9.2
7.6
1.30
1.37
mmol/l
0.68
302
1910
492
3426
1.53
15.14
2.2
2.1
30.41
29.86
s
1.26
486
3330
554
3963
1.50
14.99
1.8
1.7
1128.81
1171.77
nmol/l
0.51
414
3026
102
439
2.37
14.54
1.5
1.3
—
—
—
0
0
102
439
2.37
14.54
1.5
1.3
—
—
—
0
0
669
5000
1.45
14.40
1.8
1.5
20.67
20.40
nmol/l
0.16
590
4276
855
6681
1.41
14.37
2.2
2.2
234.79
233.39
u/l
0.01
807
6289
271
1656
1.71
14.24
3.6
3.1
4.83
4.58
kpa
0.91
262
1597
355
2328
1.60
14.15
3.8
3.3
—
—
—
0
0
134
654
2.10
14.10
2.1
1.7
—
—
—
0
0
192
1064
1.87
14.05
4.4
4.1
24.11
24.13
mmol/l
0.03
187
1041
798
6184
1.41
13.99
3.0
3.1
1535.37
1338.32
ng/l
0.41
690
5289
2289
21177
1.51
13.41
21.8
13.0
83.58
81.18
ml/min/173m2
5.46
1953
17543
149
779
1.97
13.00
2.1
2.3
452.40
506.71
ug/l
0.16
139
732
1872
16762
1.37
12.71
4.3
3.9
14.78
14.78
pmol/l
0.02
1708
15255
112
535
2.14
12.49
1.3
1.2
11.78
2.58
u/ml
—
10
53
1686
14872
1.35
12.48
4.2
3.1
66.70
49.46
u/l
6.70
1578
13882
59
210
2.85
12.39
1.2
1.2
61.77
60.07
u/l
0.07
53
193
112
543
2.11
12.03
1.3
1.2
13.50
9.37
u/ml
0.15
16
91
18
11
16.47
11.66
2.4
2.7
2.41
3.80
mg/l
0.89
18
11
2195
20293
1.42
11.49
5.3
4.6
1.92
2.12
mu/l
1.00
2026
18582
1016
8385
1.34
11.49
4.1
3.5
34.49
48.85
ng/l
1.03
736
5788
102
486
2.14
11.47
3.7
2.7
35.13
36.86
umol/l
0.25
88
440
116
583
2.03
11.34
1.3
1.2
110.86
36.93
u/ml
—
5
31
162
911
1.83
11.33
2.0
2.0
2.35
2.15
ug/l
0.09
142
815
281
1835
1.59
11.32
1.9
2.8
66.49
66.62
g/l
0.10
261
1675
63
245
2.61
11.20
1.2
1.2
137.40
46.64
u/ml
—
5
13
197
1182
1.72
11.05
12.5
10.5
24.53
24.33
mmol/l
0.41
185
1155
372
2601
1.50
10.99
9.9
8.1
1.11
1.11
mmol/l
0.00
322
2062
372
2604
1.50
10.93
9.9
8.1
5.36
5.11
kpa
4.24
352
2485
372
2605
1.50
10.91
9.9
8.1
11.78
12.28
kpa
1.16
352
2486
90
418
2.19
10.81
1.2
1.2
36.11
44.34
u/ml
—
8
43
632
4894
1.38
10.65
1.9
1.8
1.46
1.19
mg/l
1.06
482
3751
90
428
2.14
10.21
1.2
1.2
1.18
5.08
u/ml
—
5
29
77
344
2.27
10.17
1.3
1.2
—
—
—
0
0
43
144
3.02
10.11
1.9
1.5
20.09
20.72
u/ml
0.04
11
32
249
1631
1.58
9.89
4.5
4.1
92.96
91.10
ng/l
0.10
214
1436
752
6066
1.33
9.56
1.9
1.7
1.51
1.39
mmol/l
3.19
647
5103
89
436
2.08
9.37
1.1
1.2
—
9.23
—
0
6
114
610
1.91
9.36
1.4
1.3
—
—
—
0
0
2494
23827
1.55
9.20
19.6
10.2
28.54
26.83
u/l
4.90
2458
23031
264
1783
1.53
9.15
3.8
3.9
1.22
1.23
mmol/l
0.52
245
1553
63
272
2.35
9.04
1.1
1.1
—
—
—
0
0
296
2055
1.49
9.00
8.7
8.0
11.13
9.76
mmol/l
2.35
288
1965
558
4340
1.36
8.97
4.2
3.7
349.04
671.32
ng/l
0.75
435
3407
215
1395
1.59
8.90
4.1
3.7
5.29
5.14
kpa
1.43
205
1333
329
2345
1.46
8.76
10.4
8.5
95.06
95.73
%
1.06
321
2255
138
801
1.76
8.74
1.9
2.5
11.14
10.30
g/l
1.14
125
724
888
7405
1.30
8.70
3.6
3.4
2.35
2.35
mmol/l
0.28
797
6569
205
1324
1.59
8.66
4.1
3.7
2.21
1.74
mmol/l
0.82
158
980
145
858
1.73
8.59
1.9
2.5
4.03
3.68
g/l
2.64
133
784
145
859
1.73
8.55
1.9
2.5
7.52
7.32
g/l
0.70
133
784
145
859
1.73
8.55
1.9
2.5
—
—
—
0
0
118
662
1.82
8.39
2.0
3.7
1.26
2.45
ratio
—
6
57
45
172
2.64
8.36
1.3
1.2
—
—
—
0
0
51
208
2.48
8.31
1.5
1.3
90107.06
104236.76
e6/l
0.06
35
146
583
4628
1.33
8.09
1.8
1.7
33750420.80
35288466.73
pmol/l
0.02
480
3871
116
655
1.81
8.08
2.1
2.5
0.00
0.02
g/l
1.21
108
608
119
681
1.78
7.94
2.0
3.7
55.08
66.88
mg/l
0.44
86
550
86
444
1.97
7.89
1.7
1.7
—
—
—
0
0
2485
23824
1.49
7.89
27.1
16.3
78.53
78.23
umol/l
0.15
2485
23814
218
1459
1.54
7.89
12.5
9.9
93.65
93.92
%
0.28
218
1453
196
1281
1.57
7.88
1.8
1.6
—
—
—
0
0
119
683
1.78
7.86
2.0
3.7
41.97
78.67
mg/l
1.00
88
552
126
743
1.73
7.59
2.0
2.6
0.59
1.12
g/l
0.97
111
655
118
683
1.76
7.59
2.1
2.4
37.40
37.86
g/l
0.42
106
609
88
465
1.92
7.56
2.6
2.5
16.07
16.28
%
0.19
52
237
109
618
1.80
7.52
2.1
2.5
0.00
0.00
g/l
-0.00
101
572
108
613
1.79
7.42
2.1
2.5
0.00
0.00
g/l
-0.00
100
571
134
809
1.69
7.42
2.0
2.5
2.98
2.93
g/l
0.20
122
735
216
1468
1.51
7.29
12.3
9.6
1.41
1.35
%
0.33
216
1456
1192
10476
1.25
7.15
2.9
2.6
—
—
—
0
0
215
1466
1.51
7.14
12.7
9.8
0.59
0.67
%
2.41
215
1453
201
1356
1.52
7.03
1.4
1.3
382.77
202.98
u/ml
1.19
189
1249
44
182
2.44
7.01
1.4
1.2
—
—
—
0
0
194
1300
1.53
7.00
1.6
1.5
—
—
—
0
0
575
4644
1.30
6.94
5.5
3.9
1.02
1.02
kg/l
0.11
94
676
176
1159
1.55
6.87
3.8
2.8
0.33
0.26
e6/l
0.44
170
1132
126
2006
0.61
6.85
1.6
1.8
—
—
—
0
0
1517
13739
1.23
6.72
3.0
2.8
—
—
—
0
0
2187
20652
1.30
6.70
6.9
5.7
41.06
39.88
mmol/mol
4.03
2051
19169
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
126
773
1.66
6.60
2.8
3.4
0.33
0.35
u/ml
0.30
68
429
297
2189
1.40
6.55
11.2
8.9
121.03
122.19
g/l
0.42
291
2124
2411
23104
1.38
6.55
24.0
16.4
3.97
3.97
mmol/l
0.85
2365
22514
64
320
2.02
6.49
1.6
1.6
—
—
—
0
0
49
221
2.24
6.46
3.5
3.9
—
—
—
0
0
2403
23024
1.37
6.45
23.9
16.3
139.35
139.70
mmol/l
8.90
2358
22472
36
142
2.56
6.36
1.1
1.0
—
—
—
0
0
85
474
1.82
6.25
1.4
1.5
—
—
—
0
0
90
511
1.79
6.24
4.2
4.7
5.09
5.05
kpa
0.20
90
502
110
663
1.69
6.18
1.8
1.7
—
—
—
0
0
83
463
1.82
6.10
5.7
5.7
359.58
690.15
iu/ml
0.48
12
68
74
398
1.88
6.10
1.7
1.8
—
—
—
0
0
25
83
3.03
6.07
1.1
1.1
1434.52
1703.35
miu/ml
0.56
25
83
75
408
1.86
5.98
1.5
1.5
—
—
—
0
0
62
319
1.97
5.84
1.3
1.5
—
—
—
0
0
44
199
2.23
5.79
1.1
1.1
—
—
—
0
0
181
1246
1.48
5.78
11.7
11.4
—
—
—
0
0
648
5431
1.25
5.67
2.7
2.4
—
—
—
0
0
92
543
1.72
5.61
1.6
1.7
—
—
—
0
0
90
528
1.73
5.61
1.6
1.6
—
—
—
0
0
98
589
1.69
5.60
1.2
1.3
241.38
207.08
miu/ml
0.29
33
272
121
768
1.60
5.58
1.7
1.6
577.86
275.48
titre
—
7
31
94
560
1.70
5.55
1.6
1.6
—
—
—
0
0
32
129
2.50
5.45
1.7
1.6
11.08
5.74
u/l
0.45
24
110
40
180
2.24
5.35
2.8
1.4
1.82
1.33
promille
1.24
30
140
49
240
2.06
5.31
1.6
1.8
—
—
—
0
0
66
361
1.85
5.22
1.3
1.5
—
—
—
0
0
26
97
2.70
5.17
1.5
1.2
—
—
—
0
0
81
475
1.73
5.09
2.5
2.2
127.97
129.88
g/l
0.29
61
345
99
615
1.63
5.02
3.8
3.7
1.67
1.55
mg/l
0.64
94
568
38
173
2.21
4.97
1.4
1.7
—
—
—
0
0
38
177
2.16
4.72
1.2
1.2
80.00
125.88
titre
—
5
34
102
649
1.59
4.71
1.4
1.4
276.06
286.45
ug/g
0.22
65
378
114
746
1.55
4.67
2.9
2.7
—
—
—
0
0
100
640
1.58
4.52
1.2
1.1
—
—
—
0
0
99
638
1.57
4.36
1.2
1.1
—
—
—
0
0
90
567
1.61
4.36
2.3
2.2
134.43
108.57
ug/min
0.21
53
351
29
125
2.33
4.34
1.3
1.7
—
—
—
0
0
29
125
2.33
4.34
1.3
1.7
—
—
—
0
0
48
253
1.91
4.30
2.0
1.3
—
—
—
0
0
30
133
2.27
4.22
1.5
1.4
—
—
—
0
0
60
342
1.77
4.22
5.3
5.7
355.09
362.84
umol/l
0.15
52
306
15
46
3.27
4.18
1.3
1.1
—
—
—
0
0
186
1372
1.38
4.14
1.2
1.3
71.53
56.83
au/ml
—
7
81
55
308
1.80
4.11
8.0
6.6
12.40
11.53
mg/l
0.65
50
288
56
317
1.78
4.04
1.6
1.7
—
—
—
0
0
481
4040
1.23
4.02
3.2
3.0
2.47
2.45
mmol/l
3.19
429
3570
35
170
2.07
3.96
1.2
1.3
1.89
2.03
mmol/l
0.57
28
160
21
82
2.57
3.88
1.8
2.9
253.50
151.28
umol/l
—
10
47
134
945
1.44
3.87
1.8
1.9
38.67
38.58
u/l
0.02
119
827
236
1830
1.32
3.81
3.0
2.9
258.25
189.87
ng/l
0.99
204
1655
123
858
1.45
3.77
4.8
4.0
24.85
24.80
mmol/l
0.08
111
805
30
141
2.14
3.71
1.9
2.1
—
—
—
0
0
200
1523
1.34
3.67
2.3
2.4
35.83
23.37
au/ml
0.44
11
110
32
156
2.06
3.61
1.3
1.1
—
—
—
0
0
31
151
2.07
3.51
1.3
1.6
—
—
—
0
0
12
31
3.88
3.48
1.2
1.2
89.17
94.10
%
0.22
12
31
32
159
2.02
3.45
1.3
1.1
—
—
—
0
0
2252
21736
1.21
3.43
5.0
4.5
6.16
5.96
mmol/l
7.25
2059
19863
31
156
2.00
3.24
1.3
1.1
—
—
—
0
0
109
767
1.44
3.24
1.8
1.8
—
—
—
0
0
168
1272
1.34
3.23
2.8
3.5
4.39
4.47
pmol/l
0.49
150
1132
23
103
2.24
3.22
4.1
3.9
—
—
—
0
0
88
596
1.49
3.18
1.9
2.0
10.82
11.42
mg/l
0.24
83
549
63
397
1.60
3.14
1.8
1.6
—
—
—
0
0
81
542
1.51
3.11
2.3
2.2
3408.15
3675.83
u/l
0.04
24
224
31
159
1.96
3.09
1.3
1.1
—
—
—
0
0
31
159
1.96
3.09
1.3
1.1
—
—
—
0
0
64
407
1.59
3.08
2.9
3.1
0.92
0.82
nmol/l
0.82
46
311
15
56
2.69
3.05
1.1
1.1
—
—
—
0
0
16
63
2.55
2.95
1.6
2.1
—
—
—
0
0
12
37
3.25
2.93
1.3
1.5
—
—
—
0
0
21
96
2.20
2.83
1.2
1.4
151.81
169.04
mmol/24h
0.43
21
96
69
457
1.52
2.81
1.3
1.2
—
—
—
0
0
29
151
1.93
2.80
1.1
1.1
—
—
—
0
0
82
565
1.47
2.77
1.3
1.3
482.09
526.75
mg/l
0.57
74
530
20
91
2.21
2.73
1.5
1.2
—
—
—
0
0
7
14
5.01
2.73
1.0
1.1
—
—
—
0
0
65
430
1.52
2.68
1.3
1.2
247.87
260.75
u/ml
0.16
48
268
63
415
1.53
2.65
1.5
1.4
105.89
120.52
u/ml
0.45
18
69
279
2315
1.23
2.64
4.2
4.2
4.53
23.83
ug/l
3.38
235
1889
22
106
2.08
2.62
4.0
3.3
—
—
—
0
0
14
55
2.55
2.61
1.1
1.2
—
—
—
0
0
81
565
1.45
2.59
1.5
1.4
13.36
10.09
u/l
0.94
62
447
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
36
208
1.74
2.54
1.2
1.2
—
—
—
0
0
121
908
1.35
2.53
5.8
6.2
1.65
1.67
%
0.06
113
844
56
364
1.55
2.51
1.2
1.1
5.52
105.79
iu/ml
2.25
14
82
22
110
2.01
2.40
2.2
2.3
890.86
1091.77
u/ml
0.26
22
110
41
250
1.65
2.40
1.1
1.1
—
—
—
0
0
13
52
2.51
2.35
1.2
1.0
—
—
—
0
0
179
1436
1.26
2.32
9.5
7.6
25.30
24.61
mmol/l
1.81
171
1358
36
215
1.68
2.29
1.8
1.5
—
—
—
0
0
237
1967
1.22
2.27
2.0
2.0
—
—
—
0
0
35
208
1.69
2.27
1.4
1.6
—
—
—
0
0
25
134
1.87
2.26
1.2
1.2
—
—
—
0
0
56
822
0.67
2.26
1.9
1.6
2.63
4.43
mg/l
1.48
48
603
15
66
2.28
2.24
1.5
1.5
67.93
179.63
nmol/24h
0.61
15
66
599
6641
0.87
2.23
4.2
4.2
22.37
21.65
%
0.50
261
3222
9
29
3.11
2.22
1.1
1.0
—
—
—
0
0
41
256
1.61
2.21
2.9
2.7
105.22
105.36
mmol/l
0.06
41
250
41
256
1.61
2.21
2.9
2.7
3.96
4.06
mmol/l
0.81
41
250
39
242
1.62
2.16
1.9
1.7
—
—
—
0
0
2198
21379
1.15
2.10
4.8
3.9
1.44
1.31
mmol/l
12.95
2041
19628
137
1078
1.29
2.10
1.3
1.4
—
—
—
0
0
117
903
1.31
2.07
5.9
6.2
0.82
0.90
%
1.36
110
841
41
262
1.57
2.03
1.9
1.7
—
—
—
0
0
214
1780
1.22
2.03
1.9
1.9
—
—
—
0
0
22
118
1.87
2.01
2.6
2.3
94.73
95.08
%
0.02
22
113
8
26
3.08
2.01
1.1
1.7
65.38
47.50
umol/l
—
8
26
8
26
3.08
2.01
1.0
1.2
—
—
—
0
0
231
1938
1.21
2.01
2.3
2.4
5.75
7.44
ug/l
1.41
203
1739
57
393
1.46
2.00
1.7
1.6
—
—
—
0
0
57
393
1.46
2.00
1.7
1.6
—
—
—
0
0
9
32
2.82
2.00
1.2
1.3
—
—
—
0
0
23
126
1.83
1.98
1.2
1.1
—
—
—
0
0
35
217
1.62
1.97
1.1
1.1
—
—
—
0
0
29
172
1.69
1.93
1.9
1.7
—
—
—
0
0
11
45
2.45
1.93
1.4
1.1
—
—
—
0
0
107
826
1.31
1.92
3.7
3.5
85.80
5009.78
u/ml
0.84
96
701
2521
24817
1.21
1.90
35.3
20.7
40.02
40.75
%
1.70
2402
23267
2277
22243
1.14
1.87
5.3
4.4
4.53
4.65
mmol/l
6.90
2137
20693
2522
24833
1.21
1.87
35.0
20.5
254.79
249.48
e9/l
3.63
2479
24221
25
144
1.74
1.85
2.4
2.3
0.23
0.23
e9/l
0.05
20
129
25
417
0.60
1.84
1.9
1.4
—
—
—
0
0
13
59
2.21
1.84
1.2
1.1
188.13
267.18
pmol/l
—
8
44
125
993
1.27
1.81
2.2
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
130
1.78
1.81
1.1
1.1
—
—
—
0
0
18
94
1.92
1.80
1.9
2.0
—
—
—
0
0
18
94
1.92
1.80
1.9
2.0
—
—
—
0
0
7
23
3.05
1.80
1.0
1.0
—
—
—
0
0
16
80
2.01
1.80
1.1
1.4
—
—
—
0
0
42
280
1.51
1.77
2.1
2.3
36.94
24.64
mg/l
0.51
16
72
2522
24849
1.20
1.75
35.0
20.5
7.11
6.70
e9/l
13.94
2476
24161
18
95
1.90
1.75
1.9
2.0
—
—
—
0
0
168
1387
1.23
1.75
1.1
1.2
66.32
149.43
iu/ml
4.22
60
513
2522
24850
1.20
1.74
35.0
20.5
4.44
4.51
e12/l
9.07
2474
24163
20
110
1.82
1.72
1.2
1.1
—
14.00
u/ml
—
0
10
17
89
1.92
1.70
3.6
2.6
410.00
766.80
e6/l
0.89
12
70
2522
24857
1.20
1.69
35.2
20.6
134.40
136.14
g/l
6.81
2502
24514
16
82
1.96
1.69
1.9
1.6
—
—
—
0
0
74
554
1.35
1.67
1.1
1.1
2.64
5.00
u/ml
—
7
66
30
188
1.60
1.66
2.3
2.3
803.28
613.97
ml
0.75
18
128
25
150
1.67
1.63
2.6
2.3
416.50
549.12
e6/l
0.46
20
130
33
213
1.56
1.62
1.7
1.6
—
—
—
0
0
33
213
1.56
1.62
1.7
1.6
—
—
—
0
0
33
213
1.56
1.62
1.7
1.6
—
—
—
0
0
18
98
1.84
1.61
1.1
1.1
—
—
—
0
0
8
32
2.50
1.59
1.3
1.2
—
—
—
0
0
16
84
1.91
1.59
2.9
2.6
26.78
29.63
umol/l
—
9
59
15
77
1.95
1.59
3.7
2.2
1201.71
24463.81
e6/l
—
7
47
14
70
2.01
1.59
1.2
1.1
—
—
—
0
0
52
372
1.41
1.56
1.1
1.1
—
—
—
0
0
19
107
1.78
1.54
1.0
1.1
—
—
—
0
0
35
232
1.52
1.54
1.6
1.4
270.64
280.81
mosm/kgh2o
0.78
22
182
21
122
1.73
1.54
2.1
1.7
—
—
—
0
0
21
122
1.73
1.54
2.1
1.7
—
—
—
0
0
437
4831
0.89
1.54
2.9
3.0
0.65
0.77
ug/l
2.51
301
3190
66
493
1.35
1.53
2.7
3.5
186.49
891.49
u/ml
0.74
60
460
67
502
1.34
1.53
1.3
1.3
3.83
3.84
mmol/l
0.01
60
470
69
520
1.34
1.52
1.5
2.0
2.28
4.98
iu/l
4.84
16
184
64
479
1.34
1.48
1.3
2.1
0.86
0.83
nmol/l
0.13
52
398
113
913
1.25
1.47
2.3
1.9
—
—
—
0
0
65
488
1.34
1.47
1.3
1.5
9.00
29.01
e6/l
0.88
43
372
65
488
1.34
1.47
1.3
1.5
222.54
819.11
e6/l
1.14
46
392
26
163
1.60
1.46
1.1
1.2
42.56
42.86
mg/l
0.01
18
131
7
28
2.50
1.45
2.9
2.3
—
—
—
0
0
7
28
2.50
1.45
1.6
1.3
—
—
—
0
0
6
22
2.73
1.43
1.0
1.4
—
—
—
0
0
23
141
1.64
1.41
2.1
1.9
—
—
—
0
0
16
88
1.82
1.41
1.1
1.0
—
—
—
0
0
20
118
1.70
1.41
1.8
1.8
—
—
—
0
0
62
466
1.34
1.41
1.5
1.4
—
—
—
0
0
105
853
1.24
1.33
1.5
1.4
28.24
30.19
iu/l
0.26
83
719
6
24
2.50
1.30
1.3
1.2
—
—
—
0
0
8
34
2.36
1.29
1.1
1.2
—
—
—
0
0
38
268
1.42
1.28
1.4
1.4
224.84
323.01
pmol/l
1.82
32
236
12
62
1.94
1.27
1.0
1.1
90.00
91.86
%
—
7
35
52
389
1.34
1.24
1.6
2.0
6.52
5.07
mmol/24h
0.34
45
344
8
36
2.23
1.24
2.0
1.6
123.23
124.17
ng/l
—
8
36
14
78
1.80
1.21
1.6
2.3
—
31411.94
—
0
16
2303
22644
1.11
1.20
5.6
4.9
2.67
2.76
mmol/l
4.79
2142
20943
20
125
1.60
1.17
1.5
1.4
—
—
—
0
0
19
118
1.61
1.14
1.8
1.8
—
—
—
0
0
22
142
1.55
1.14
2.9
1.7
—
—
—
0
0
24
159
1.51
1.12
1.1
1.1
299.88
291.52
mg/l
0.03
17
133
87
709
1.23
1.11
6.2
4.2
3.91
3.90
mmol/l
0.07
87
700
37
270
1.38
1.06
1.5
1.4
—
—
—
0
0
2247
22102
1.09
1.05
5.0
4.4
1.38
1.45
mmol/l
13.93
2082
20440
82
670
1.23
1.04
1.7
1.6
323.05
309.81
mu/l
0.08
75
609
17
106
1.61
1.02
1.4
1.8
—
—
—
0
0
37
273
1.36
1.01
1.5
1.5
—
—
—
0
0
99
828
1.20
1.01
2.0
1.8
—
—
—
0
0
16
99
1.62
1.00
1.6
1.4
—
—
—
0
0
16
99
1.62
1.00
1.6
1.4
—
—
—
0
0
37
274
1.36
0.99
1.5
1.5
—
—
—
0
0
11
61
1.81
0.98
1.0
1.4
92.83
90.57
%
—
6
35
5
23
2.18
0.98
1.2
1.2
127.20
226.36
ug/l
—
5
11
52
658
0.79
0.95
1.6
1.4
—
—
—
0
0
19
125
1.52
0.94
1.5
1.4
—
—
—
0
0
37
277
1.34
0.93
1.7
1.5
—
—
—
0
0
37
277
1.34
0.93
1.7
1.5
—
—
—
0
0
9
52
1.73
0.92
1.0
1.2
—
—
—
0
0
12
71
1.69
0.88
1.2
1.1
—
—
—
0
0
50
628
0.79
0.88
1.8
1.5
—
—
—
0
0
15
95
1.58
0.87
2.7
2.5
—
—
—
0
0
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
23
161
1.43
0.86
1.3
1.3
—
—
—
0
0
61
497
1.23
0.83
1.9
2.0
183.29
206.81
pmol/l
1.07
55
469
70
581
1.21
0.81
1.3
1.2
—
—
—
0
0
36
276
1.31
0.80
1.6
1.5
0.22
0.31
nmol/l
0.92
24
210
70
582
1.21
0.80
1.3
1.3
—
—
—
0
0
35
268
1.31
0.79
1.6
1.5
—
—
—
0
0
202
1824
1.12
0.78
2.8
2.6
58.43
66.96
ml/min/173m2
2.27
82
702
12
74
1.62
0.78
3.4
2.4
—
—
—
0
0
35
269
1.31
0.77
1.6
1.5
—
—
—
0
0
35
270
1.30
0.76
1.6
1.5
—
—
—
0
0
28
370
0.75
0.75
1.7
1.5
—
—
—
0
0
11
67
1.64
0.75
1.2
1.1
—
—
—
0
0
13
83
1.57
0.75
1.2
1.8
—
—
—
0
0
40
316
1.27
0.73
1.1
1.1
—
—
—
0
0
23
167
1.38
0.73
1.3
1.3
1.06
1.15
u/ml
—
9
96
5
25
2.00
0.72
1.2
1.5
—
—
—
0
0
7
39
1.80
0.72
1.0
1.8
—
—
—
0
0
9
57
1.58
0.71
1.1
1.5
-0.98
0.71
mmol/l
—
9
51
36
283
1.28
0.69
1.4
1.3
7.89
7.38
mmol/l
0.37
31
250
11
69
1.60
0.68
1.2
1.2
—
—
—
0
0
11
69
1.60
0.68
1.3
1.1
—
—
—
0
0
37
293
1.27
0.68
1.2
1.0
1.17
2.43
u/ml
2.63
13
129
21
153
1.38
0.67
1.2
1.2
—
—
—
0
0
10
62
1.62
0.65
1.2
1.1
—
—
—
0
0
5
29
1.73
0.64
2.0
2.2
—
—
—
0
0
18
129
1.40
0.63
1.2
1.2
141.44
137.17
nmol/l
0.19
18
129
13
87
1.50
0.63
2.0
1.8
—
—
—
0
0
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
5
30
1.67
0.61
2.0
2.2
—
—
—
0
0
5
30
1.67
0.61
6.6
1.5
—
—
—
0
0
27
346
0.78
0.61
1.6
1.4
—
—
—
0
0
27
346
0.78
0.61
1.6
1.4
—
—
—
0
0
27
346
0.78
0.61
1.6
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
27
345
0.78
0.60
1.6
1.4
—
—
—
0
0
11
72
1.53
0.59
2.1
1.8
0.43
1.20
ug/l
1.84
11
64
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
16
219
0.73
0.57
2.0
1.6
—
—
—
0
0
11
73
1.51
0.56
1.3
1.1
—
—
—
0
0
6
38
1.58
0.54
1.3
1.2
—
6.23
—
0
7
23
178
1.29
0.53
1.8
1.5
0.95
0.95
g/l
0.00
23
178
295
2773
1.07
0.52
9.4
6.9
—
—
—
0
0
9
63
1.43
0.52
1.2
1.1
—
—
—
0
0
12
83
1.45
0.51
1.7
1.8
16.58
19.49
ug/l
0.19
12
74
18
136
1.33
0.49
2.7
2.8
29.29
42.13
%
—
7
78
19
146
1.30
0.47
1.3
1.3
—
—
—
0
0
7
48
1.46
0.46
1.1
1.2
—
—
—
0
0
25
201
1.25
0.45
1.2
1.4
—
—
—
0
0
10
69
1.45
0.44
2.4
2.9
—
—
—
0
0
10
69
1.45
0.44
2.4
2.9
—
—
—
0
0
42
358
1.18
0.43
2.0
1.6
—
—
—
0
0
23
184
1.25
0.43
2.8
2.1
5.71
1.75
u/field
—
7
83
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
15
113
1.33
0.42
1.4
1.6
9.57
9.03
ug/l
0.08
15
99
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
19
149
1.28
0.41
1.3
1.3
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
0.09
—
0
9
0
16
0.00
0.41
0.0
1.0
—
0.11
—
0
9
0
17
0.00
0.40
0.0
1.0
—
0.10
—
0
11
194
1818
1.07
0.40
2.2
2.2
11.21
12.97
nmol/l
2.63
171
1617
41
352
1.17
0.40
1.4
1.2
2.54
4.26
u/ml
0.68
13
119
260
2744
0.94
0.40
4.5
4.5
31.26
32.41
%
0.79
180
1870
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
54
476
1.14
0.38
4.3
3.6
26.38
26.57
mg/l
0.01
34
295
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
64
571
1.12
0.38
1.1
1.1
—
—
—
0
0
15
116
1.29
0.37
8.3
6.1
30.20
58.54
u/ml
—
5
28
16
125
1.28
0.37
1.1
1.1
0.90
1.14
u/l
—
5
69
17
134
1.27
0.37
1.3
1.2
1.03
1.05
ratio
—
10
51
6
42
1.43
0.35
2.0
1.3
—
—
—
0
0
28
236
1.19
0.35
1.3
1.4
21819.29
92180.97
e6/l
1.28
17
140
6
44
1.36
0.34
2.2
2.2
14.50
19.38
umol/l
—
6
44
114
1056
1.08
0.34
1.1
1.0
—
—
—
0
0
6
45
1.33
0.33
1.2
1.1
—
—
—
0
0
23
275
0.83
0.33
1.1
1.1
—
—
—
0
0
6
46
1.31
0.33
1.0
1.2
—
—
—
0
0
294
3070
0.95
0.33
1.4
1.4
—
—
—
0
0
11
83
1.33
0.32
1.1
1.1
—
—
—
0
0
42
371
1.13
0.30
1.3
1.1
3.97
2.30
u/ml
0.20
20
195
15
120
1.25
0.30
1.2
1.1
—
—
—
0
0
57
517
1.10
0.28
8.4
8.7
104.20
105.47
mmol/l
1.82
51
458
67
731
0.91
0.28
2.0
1.8
—
—
—
0
0
37
329
1.13
0.26
1.2
1.1
2.95
5.73
u/ml
0.58
17
168
9
73
1.23
0.25
1.3
1.2
116.22
108.62
%
—
9
64
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
3.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
16
135
1.19
0.21
9.8
13.8
1115.81
847.25
nmol/l
1.73
16
128
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
4292.29
—
0
7
0
13
0.00
0.21
0.0
1.0
—
2.24
—
0
7
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
5.4
—
—
—
0
0
28
249
1.13
0.20
1.1
1.1
1.91
2.76
u/ml
—
10
114
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
9
113
0.80
0.20
1.2
1.3
—
—
—
0
0
30
269
1.12
0.19
1.5
1.5
2917.67
1717.01
e6/l
0.35
24
195
27
241
1.12
0.19
2.6
2.3
—
—
—
0
0
37
338
1.10
0.18
1.2
1.1
—
—
—
0
0
19
216
0.88
0.17
1.3
1.0
0.07
0.34
u/ml
—
6
71
8
68
1.18
0.16
1.8
1.4
—
—
—
0
0
35
321
1.09
0.16
1.2
1.1
0.57
1.85
u/ml
1.02
16
141
37
344
1.08
0.13
1.5
1.2
8.81
5.30
u/ml
0.41
16
149
32
297
1.08
0.12
1.3
1.1
—
—
—
0
0
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
29
273
1.06
0.08
2.2
1.7
—
—
—
0
0
6
70
0.86
0.07
1.3
1.2
—
—
—
0
0
14
153
0.91
0.07
1.1
1.1
—
—
—
0
0
7
84
0.83
0.07
1.3
1.2
—
—
—
0
0
19
178
1.07
0.05
1.2
1.5
3.18
4.70
ug/l
0.41
14
152
830
8259
1.01
0.05
4.3
4.9
2.47
2.77
ug/l
0.31
732
7424
32
307
1.04
0.05
1.8
1.5
—
—
—
0
0
16
167
0.96
0.01
1.4
1.5
71.25
83.62
umol/l
2.00
16
167
64
641
1.00
0.00
1.5
1.5
—
—
—
0
0
19
186
1.02
0.00
1.3
1.4
104.93
214.56
pmol/l
1.38
19
186
21
214
0.98
0.00
2.3
2.4
—
—
—
0
0
30
304
0.99
0.00
1.2
1.1
0.18
1.67
u/ml
4.14
15
158
10
98
1.02
0.00
2.0
1.6
—
1679021.43
—
0
7
15
147
1.02
0.00
1.2
1.3
1.53
1.57
g/l
0.20
15
147
14
137
1.02
0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
2.56
—
0
9
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
99
0.91
-0.00
1.8
1.4
24.33
28.12
umol/l
—
9
94
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_PSORI_NAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORI_NAS | 1.614 [1.41, 1.85] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.201 |
During the follow-up period (1.1.1998 — 31.12.2019), 797 out of 4508 females with L12_PSORI_NAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORI_NAS | 2.294 [2.01, 2.61] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1294 out of 5256 males with L12_PSORI_NAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_PSORI_NAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.15% | 0.417% |
| 5 | 0.863% | 2.543% |
| 10 | 2.182% | 6.287% |
| 15 | 4.563% | 11.503% |
| 20 | 8.04% | 18.71% |
Relationships between endpoints
↥Index endpoint: L12_PSORI_NAS – Other and unspecified psoriasis
GWS hits: 8
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data